Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,802.00    42.00 (1.12%)
Bid:
3,796.00
Ask:
3,806.00
Spread: 10.00 (0.263%)
Market Cap: £1.07b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Interim Management Statement

27 Oct 2008 07:00

RNS Number : 6716G
4imprint Group PLC
27 October 2008
 



4imprint Group plc 

Interim Management Statement

The Board of 4imprint Group plc today issues its interim management statement for the period from 29 June 2008 to 27 September 2008

Group sales in Q3 at £42.4m were 20% ahead of the same period last year, and cumulative sales for the 9 months, at £120.5m, were 15% ahead. Seasonally, the third quarter is less strong than the second quarter.

In the Divisions, the Direct Marketing Division achieved Q3 sales in sterling of £25.6m, 30% ahead of last year and £68.6m for the 9 months, 24% ahead. 

The End User Division achieved Q3 sales of £12.7m, 13% ahead of last 

year, and £39.0for the 9 months, 15% ahead. 

Trade Division sales for Q3, at £4.1m, were 9% down on the same period 

last year, while for the 9 months sales were £12.9m, 15lower. Total sales, including inter divisional sales were £15.2m, 18% lower. 

Unaudited cumulative Q3 Group operating profit before defined benefit pension costs, share option charges and exceptional costs was £7.0m, 3% ahead of last year. 

Trading conditions generally in the main markets served by the Group, notably North America and the UK, remain uncertain and the Group continues to take appropriate initiatives to mitigate these conditions.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSBDGGSDGGIS
Date   Source Headline
7th Aug 20247:00 amRNSHalf-year Report
17th Jun 202411:51 amRNSHolding(s) in Company
29th May 20249:27 amRNSEBT Purchase
22nd May 20243:25 pmRNSResult of AGM
22nd May 20247:00 amRNSCFO Succession
22nd May 20247:00 amRNSAGM Statement
16th May 20249:25 amRNSHolding(s) in Company
2nd May 20249:19 amRNSHolding(s) in Company
16th Apr 202410:23 amRNSAnnual Financial Report
3rd Apr 20243:42 pmRNSDirector/PDMR Shareholding
28th Mar 20241:58 pmRNSDirector/PDMR Shareholding
28th Mar 20249:05 amRNSEBT Purchase
13th Mar 20247:00 amRNSFinal Results
28th Feb 20248:33 amRNSHolding(s) in Company
13th Feb 20244:49 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSTrading Statement
8th Jan 20248:27 amRNSBlock listing Interim Review
13th Dec 20238:52 amRNSCommittee changes
4th Dec 20231:23 pmRNSHolding(s) in Company
14th Nov 202312:28 pmRNSEBT Purchase
7th Nov 20237:00 amRNSTrading Statement
9th Oct 20238:17 amRNSEBT Purchase
21st Sep 20238:15 amRNSHolding(s) in Company
18th Aug 20238:09 amRNSDirectorate Change
1st Aug 20238:47 amRNSTrading Statement
31st Jul 20239:20 amRNSTotal Voting Rights
26th Jul 20233:23 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSPension Buy-in Transaction
29th Jun 20239:06 amRNSAdditional Listing
27th Jun 20239:41 amRNSBlock listing Interim Review
6th Jun 20231:36 pmRNSEBT Purchase
24th May 20232:12 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
12th May 20234:01 pmRNSHolding(s) in Company
17th Apr 20235:30 pmRNSAnnual Financial Report
14th Apr 20232:53 pmRNSHolding(s) in Company
29th Mar 20238:38 amRNSDirector/PDMR Shareholding
28th Mar 20238:04 amRNSEBT Purchase
15th Mar 20237:00 amRNSFinal Results
20th Jan 20237:00 amRNSTrading Statement
7th Dec 20223:38 pmRNSEBT Purchase
4th Nov 20227:00 amRNSTrading Statement
27th Oct 202212:42 pmRNSDirector Declaration
10th Oct 20229:01 amRNSEBT Purchase
16th Sep 20221:49 pmRNSHolding(s) in Company
12th Sep 20229:21 amRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
2nd Aug 20229:13 amRNSHolding(s) in Company
1st Aug 20228:39 amRNSHolding(s) in Company
1st Aug 20228:00 amEQSBloc Ventures: Demand for deep tech unhindered by downturn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.